Categories AlphaGraphs, Earnings, Retail
Key highlights from Walgreens Boots Alliance’s (WBA) Q3 2024 earnings results
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today.
Sales increased 2.6% year-over-year to $36.4 billion. Sales rose 2.5% on a constant currency basis.
Net earnings were $344 million, or $0.40 per share, compared to $118 million, or $0.14 per share, last year. Adjusted EPS was $0.63, down 36.6% YoY.
Revenue beat estimates while earnings fell short.
The company is lowering fiscal year 2024 adjusted EPS guidance to $2.80-2.95, reflecting challenging pharmacy industry trends and a worse-than-expected US consumer environment.
The stock plunged 15% in premarket hours on Thursday following the announcement.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
